$2.41 Billion is the total value of HHLR ADVISORS, LTD.'s 32 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BGNE | New | BEIGENE LTDsponsored adr | $622,467,000 | – | 4,437,953 | +100.0% | 25.82% | – |
| JD | New | JD COM INCspon adr cl a | $314,813,000 | – | 15,041,243 | +100.0% | 13.06% | – |
| CBPO | New | CHINA BIOLOGIC PRODS HLDGS I | $208,844,000 | – | 2,751,200 | +100.0% | 8.66% | – |
| TAL | New | TAL ED GROUPsponsored ads | $199,452,000 | – | 7,475,723 | +100.0% | 8.27% | – |
| BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $193,520,000 | – | 1,411,830 | +100.0% | 8.03% | – |
| MDLZ | New | MONDELEZ INTL INCcl a | $141,276,000 | – | 3,529,264 | +100.0% | 5.86% | – |
| FGEN | New | FIBROGEN INC | $92,712,000 | – | 2,003,287 | +100.0% | 3.85% | – |
| WUBA | New | 58 COM INCspon adr rep a | $80,482,000 | – | 1,484,641 | +100.0% | 3.34% | – |
| BPMC | New | BLUEPRINT MEDICINES CORP | $77,142,000 | – | 1,430,949 | +100.0% | 3.20% | – |
| KANG | New | IKANG HEALTHCARE GROUP INCsponsored adr | $59,567,000 | – | 2,922,834 | +100.0% | 2.47% | – |
| MYOK | New | MYOKARDIA INC | $41,938,000 | – | 858,340 | +100.0% | 1.74% | – |
| LN | New | LINE CORPsponsored adr | $41,197,000 | – | 1,207,763 | +100.0% | 1.71% | – |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $39,014,000 | – | 1,388,888 | +100.0% | 1.62% | – |
| PDD | New | PINDUODUO INCsponsored ads | $38,823,000 | – | 1,730,096 | +100.0% | 1.61% | – |
| SNAP | New | SNAP INCcl a | $38,157,000 | – | 6,925,129 | +100.0% | 1.58% | – |
| BEDU | New | BRIGHT SCHOLAR ED HLDGS LTDsponsored ads | $36,709,000 | – | 3,985,797 | +100.0% | 1.52% | – |
| BILI | New | BILIBILI INCspons ads rep z | $31,776,000 | – | 2,177,931 | +100.0% | 1.32% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $29,410,000 | – | 2,229,708 | +100.0% | 1.22% | – |
| TME | New | TENCENT MUSIC ENTMT GROUPspon ads | $19,440,000 | – | 1,470,491 | +100.0% | 0.81% | – |
| LOXO | New | LOXO ONCOLOGY INC | $18,391,000 | – | 131,300 | +100.0% | 0.76% | – |
| GTHX | New | G1 THERAPEUTICS INC | $18,182,000 | – | 949,431 | +100.0% | 0.75% | – |
| IQ | New | IQIYI INCsponsored ads | $16,845,000 | – | 1,132,816 | +100.0% | 0.70% | – |
| SOHU | New | SOHU COM LTDsponsored ads | $13,971,000 | – | 802,034 | +100.0% | 0.58% | – |
| YY | New | YY INC | $11,582,000 | – | 193,490 | +100.0% | 0.48% | – |
| ARVN | New | ARVINAS INC | $8,031,000 | – | 625,000 | +100.0% | 0.33% | – |
| RCUS | New | ARCUS BIOSCIENCES INC | $4,577,000 | – | 425,000 | +100.0% | 0.19% | – |
| NEW | New | PUXIN LTDads | $2,896,000 | – | 490,050 | +100.0% | 0.12% | – |
| PTI | New | PROTEOSTASIS THERAPEUTICS IN | $2,806,000 | – | 865,923 | +100.0% | 0.12% | – |
| EIDX | New | EIDOS THERAPEUTICS INC | $2,458,000 | – | 178,600 | +100.0% | 0.10% | – |
| SFUN | New | FANG HLDGS LTDadr | $2,145,000 | – | 1,500,000 | +100.0% | 0.09% | – |
| NTGN | New | NEON THERAPEUTICS INC | $1,572,000 | – | 312,500 | +100.0% | 0.06% | – |
| MLCO | New | MELCO RESORT ENTERTAINMENT Ladr | $455,000 | – | 25,814 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.